Nonprofit · EIN 20-3256212
EROWID CENTER
Tax-exempt · GRASS VALLEY, CA 95945
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | 990 | $423,518 | $660,937 | -$237,419 | $554,990 | $21,305 | $533,685 |
| December 31, 2023 | 990 | $703,768 | $775,164 | -$71,396 | $539,007 | $25,420 | $513,587 |
Financial details: 990 for the year ended December 31, 2024
Revenue
- Contributions, gifts and grants
- $260,960
- Membership dues
- $161,801
- Program service revenue
- $157,697
- Investment income
- $4,861
- Other revenue
- $0
Expenses
- Grants and similar amounts paid
- $100
- Compensation of officers, directors and key employees
- $200,620
- Other salaries and wages
- $20,800
- Salaries, compensation and benefits (total)
- $252,524
- Professional fundraising fees
- $0
- Legal fees
- $500
- Occupancy
- $24,082
- Travel
- $2,977
- Program services (functional)
- $551,518
- Management and general (functional)
- $77,332
- Fundraising (functional)
- $32,087
Balance sheet and other
- Total assets, start of year
- $539,007
- Total assets, end of year
- $554,990
- Total liabilities, end of year
- $21,305
- Net assets, end of year
- $533,685
- Publicly traded securities
- $80,050
- Gross receipts
- $423,518
- Employees
- 3
- Volunteers
- 280
- Year formed
- 2005
- State of legal domicile
- CA
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2024, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| C Blomquist | Treasurer Trustee or director, Officer | 50 | $81,000 | $19,386 |
| B Lincoln | President Trustee or director, Officer | 60 | $81,000 | $19,386 |
| J Dumpert | Secretary Trustee or director, Officer | 1 | $0 | $0 |
| E Fenster | Director Officer | 0.7 | $0 | $0 |
| S Moore | Director Officer | 0.5 | $0 | $0 |
990 for the year ended December 31, 2023: 5 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| C Blomquist | Treasurer Trustee or director, Officer | 60 | $81,000 | $18,478 |
| B Lincoln | President Trustee or director, Officer | 60 | $81,000 | $18,478 |
| J Dumpert | Secretary Trustee or director, Officer | 1 | $0 | $0 |
| E Fenster | Director Trustee or director | 0.7 | $0 | $0 |
| S Moore | Director Trustee or director | 0.8 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 1116 BOX PO, GRASS VALLEY, CA 95945-0000
- In care of
- % BRIAN LINCOLN
- Principal officer (990 for 2024)
- C Blomquist, PO Box 1116, Grass Valley, CA 95945
- Signed the 990
- C Blomquist, Treasurer
- Phone
- (415) 963-3559
- Website
- ErowidCenter.org
California records
California keeps its own records of charities and corporations. Search them by EIN 20-3256212 or by the name EROWID CENTER.
- Attorney General, Registry of Charities and Fundraisers
- Registration status and filed reports (CT-TR-1, RRF-1)
- Secretary of State, bizfile Online
- Corporation status, entity number, agent for service
- Franchise Tax Board
- Entity status letter (state tax exemption, good standing)
Mission
To provide & facilitate access to objective, accurate, and non-judgmental information about psychoactive plants chemicals, drugs, technologies, and related issues. Erowid also supports and trains information providers and assists medical, legal, and scientific experts in developing resources.
Program accomplishments
- Erowid Center runs a laboratory drug checking program that analyzes the contents of street samples of psychoactive drugs, including: novel psychoactive substances (NPS); stimulants and euphoric stimulants; psychedelics; research chemicals; street heroin; fentanyl; and other opioids; as well as commercial and counterfeit pharmaceuticals. Samples are tested at a licensed laboratory and the results are published online at DrugsData.org. Erowid's DrugsData project also collects, manages, reviews, and presents laboratory-testing results from other US and international organizations. This information is made publicly available to help harm-reduction efforts, medical personnel, researchers, and the public. In 2024, 1,001 samples were tested through this project and 199 unique substances were detected. These results were published alongside results for 799 samples tested by other organizations. An average of 30,000 result pages were viewed per day, with an average 15,000 unique visitors per day. Results were regularly published on social media to Erowid's more than 180,000 followers. Erowid continued its partnerships with research groups doing lab validation of on-site analytical tools such as compact FTIR and fentanyl and xylazine test strips. A portion of the expenses and revenue associated with DrugsData research are included in the Drug Trend & Novel Psychoactive Substance and Research program services described below. This service was interrupted on April 10, 2024, due to an unexpected regulatory change and was unable to conduct operations through the end of 2024.Expenses $191,552 · revenue $136,494
- Erowid Center develops, maintains, and provides free access to an online collection of more than 96,700 documents, images, and other media files related to psychoactive plants and drugs. The collection contains information, essays and articles authored by a broad spectrum of contributors including health care professionals, substance abuse counselors, toxicologists, chemists, therapists, law enforcement agents, lawyers, anthropologists, experiential experts, writers, media, educators, and the general public. Note that Erowid's Experience Reports project is tracked as a separate program service. Erowid also shared information via social media accounts on Twitter, Instagram, and Facebook.Expenses $119,090
- Erowid Center's mission includes collecting, organizing, and preserving resources about psychoactives for the historical record. In 2024, Erowid's primary archiving project was the Shulgin Collection. Erowid nearly completed digitizing Alexander and Ann Shulgin's personal papers, audio recordings, and documents. Erowid also organized, identified, and created metadata for digitized files. By the end of the year, Erowid had created index entries for 55,000 scanned documents in the collection of around 230,000 total scanned items. Erowid Center maintains a physical space designed to allow processing of historical archive collections (organizing, scanning, photographing, and digitizing) as well as permanent storage of some library archives/collections.Expenses $110,825
- 4. Research, Surveys, & Research Improvement - Research, Surveys, & Research Improvement - In 2024, Erowid co-authored 4 published peer-reviewed journal articles. We participated in writing and submitting two additional papers, not published in 2024. We worked on multiple scientific/medical research projects as part of the Lab Validation subproject of our DrugsData program. Erowid improves scientific, medical, and sociological information about psychoactive substances and those who use them by promoting participation in studies and surveys produced by academics, educational institutions, and related organizations. Erowid works directly with scientists-in areas where we have specialized knowledge-to help design credible studies and provide editing, reviewing, and fact-checking for resulting academic publications. Several additional papers were published in academic journals using Erowid's Experience Vault data as a major part of their primary dataset. Erowid Center's resources are referenced in hundreds of journal articles, books, and media articles each year.Expenses $44,319 · revenue $15,881
- 5. Drug Trend & Novel Psychoactive Substance Tracking - Tracking new psychoactive medicines, technologies, research chemicals, psychedelics, and novel psychoactive substances (NPS) is one of Erowid Center's areas of expertise. With the objective of educating the public on the risks and benefits associated with emerging drugs, we 1) monitor the availability, use patterns, and effects of these substances through consultation with volunteers, allied organizations, medical professionals, submissions, and online forums; 2) analyze psychoactive chemicals through our DrugsData program (tracked as a separate project); 3) coordinate between experts and researchers in the field; 4) educate writers and authors for media, news, and books; and 5) publish information about these substances, online and in print. In 2024, Erowid's DrugsData encountered 35 unidentifiable novel substances in submitted samples. With the help of a network of international experts, we were able to identify 14 of these. Erowid worked with multiple groups to monitor the contents of street 'heroin'/down/dope/fentanyl as well as cocaine and methamphetamine. Erowid helped identify and characterize contaminants, synthesis byproducts, and novel substances. We leveraged our expertise to help develop systems to mitigate the societal damage of the "opioid epidemic", improve state- and city-level drug supply monitoring, and provide facts to help public health messaging around misrepresented and contaminated street drugs.Expenses $40,041
- 6. Education and Educational Materials, Books, and Gifts - Erowid provided direct education services by answering online questions from the public via email, social media, and other communication systems. Erowid maintains a social media presence via Instagram, Twitter, Facebook, and LinkedIn through which we publish new information, drug checking results, news and research updates, and answer questions related to psychoactives. We distribute books, handouts, and teaching materials about psychoactive drugs, plants, practices, and technologies to members and the general public, furthering our educational mission.Expenses $18,015 · revenue $4,951
- 7. Experience Reports Collection - Erowid Center solicited, reviewed, and published first-hand reports of people's experiences with psychoactive plants, drugs, and technologies. Erowid's Experience Reports generated information about novel and classic psychoactive materials as well as aggregate data about why and how people use psychoactives, both for current factual documentation and for the historical record. Researchers, academics, medical professionals, and the public use the results for educational purposes and as data for peer-reviewed articles and publications. Reports are reviewed and edited before being published. Trained volunteers perform a portion of the work under the supervision of Erowid staff. In 2024, Erowid crew completed 5,112 "triages" (reading and rating an experience report), review-edited for publication 285, and published 238, ending the year with 42,926 published reports in the collection covering 890 substances. Approximately 21 million experience reports were viewed during the year.Expenses $15,306
- 8. Events & Conferences - Erowid conducts educational outreach in person and online at conferences, seminars, festivals, and meetings. In 2024, we had monthly technical meetings with research partners monitoring street drug contents and contaminants as part of our DrugsData project until August 2024. Erowid Center spoke and participated in a four-day online conference about drug checking, lab analysis, and in-person street drug user direct care.Expenses $5,220
- 9. Information Network - EEN - Erowid Center works with a network of both professionally trained and self-taught experts with knowledge about psychoactive plants, chemicals, and technologies. Erowid Expert Network (EEN) members volunteer to share their expertise for the purpose of educating the public and improving the quality of information about this topic. The EEN facilitates making connections between those who are seeking information and experts who can help them. This furthers Erowid Center's mission by helping to improve both internal and external educational resources through increased fact checking and review.Expenses $5,026
- 10. Erowid Extracts Educational Newsletter - Erowid Center continued to collect information for a future newsletter issue centered on public drug checking and our DrugsData laboratory drug checking program (program expenses tracked separately). This advertisement-free print publication is distributed to members when published and past issues are distributed for free at conferences we attend. A complete digital version and constituent articles are later published online for free access by the general public. More than 17,000 copies of previous issues of Erowid Extracts were viewed/downloaded in 2024, and thousands of people read individual articles from previous issues online. Back issues were also distributed worldwide for free to related organizations, members, and events.Expenses $2,124
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | Not on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 20-3256212
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 2007
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Mental health and crisis intervention (F99)
- Assets (IRS master file)
- $554,990
- Income (IRS master file)
- $423,518
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2024 | $423,518 | $660,937 | $554,990 | XML |
| 990 | December 2023 | $703,768 | $775,164 | $539,007 | XML |
| 990 | December 2022 | $666,519 | $778,248 | $432,219 | IRS |
| 990 | December 2021 | $699,750 | $632,579 | $785,140 | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 20-3256212).
Questions about EROWID CENTER
- What is the EIN of EROWID CENTER?
- The employer identification number (EIN) of EROWID CENTER is 20-3256212.
- Is EROWID CENTER tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2007.
- Are donations to EROWID CENTER tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does EROWID CENTER file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of EROWID CENTER due?
- The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did EROWID CENTER last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2024.
- Who is the principal officer of EROWID CENTER?
- The 990 for the year ended December 31, 2024 names C Blomquist.
- Who are the officers and directors of EROWID CENTER?
- The 990 for the year ended December 31, 2024 lists 5 people; 2 received compensation from the organization, the highest $81,000 (C Blomquist, Treasurer).
- How much revenue does EROWID CENTER have?
- On its 990 for the year ended December 31, 2024 it reported revenue of $423,518, expenses of $660,937 and total assets of $554,990 at year end.
Other nonprofits in GRASS VALLEY
- COMMON PURPOSE EIN 82-0851223 · last filed 990 for 2025
- ZENDO PROJECT INC EIN 88-3852704 · last filed 990 for 2025
- YUBA HARM REDUCTION COLLECTIVE EIN 88-1883018 · last filed 990 for 2025
- SPIRIT-PEERS FOR INDEPENDENCE & RECOVERY INC EIN 82-0546046 · last filed 990 for 2025
- WELCOME HOME VETS EIN 27-1398136 · last filed 990-EZ for 2025
- WESTERN SIERRA MEDICAL CLINIC INC EIN 94-2279011 · last filed 990 for 2024
- JOHN MUIR CHARTER SCHOOLS EIN 80-0005828 · last filed 990 for 2025
- HOSPICE OF THE FOOTHILLS EIN 94-2674084 · last filed 990 for 2025
All nonprofits in GRASS VALLEY · California · Mental health and crisis intervention